Meihua Tu

Director. Computational Chemistry and Cheminformatics, Oncology Targeted Discovery

Role
Director of Computational Chemistry, Chemistry and Dmpk, Oncology Targeted Discovery at AstraZeneca
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Meihua Tu

Passionate drug hunter with a proven track record of innovation, scientific leadership, and impact across multiple therapeutic areas. Successfully advanced numerous programs from hit identification through candidate selection, made key contributions—often as co-inventor—to several assets that progressed into late-stage clinical development. Experienced leader in managing and mentoring high-performing computational chemistry and cheminformatics teams. Proven ability to bridge deep scientific insight with strategic execution. Author of over 50 peer-reviewed publications and inventor on 14 patents.

Experience

  1. Director of Computational Chemistry, Chemistry and Dmpk, Oncology Targeted Discovery

    AstraZeneca

    May 2023 — Present · Waltham, MA, US

Education

  • Case Western Reserve University

    Ph.D., Computational Chemistry

  • Peking University

    BS, Chemistry

Skills

  • Gpcrs
  • Cheminformatics
  • Clinical Development
  • Adme
  • Organic Chemistry
  • Biotechnology
  • Lifesciences
  • Lc-Ms
  • Life Sciences
  • Medicinal Chemistry
  • Drug Development
  • Drug Discovery
  • Organic Synthesis
  • Computational Chemistry
  • Dmpk
  • Drug Metabolism
  • Qsar
  • Drug Design
  • Virtual Screening
  • Synthetic Organic Chemistry
  • Lead Change
  • Pharmaceutical Industry
  • Parallel Synthesis

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Meihua Tu — Director of Computational Chemistry, Chemistry and Dmpk, Oncology Targeted Discovery at AstraZeneca in Cambridge, MA, US | Unifers